Cargando…

Clinical manifestations and treatment management of hospitalized patients with zinc phosphide poisoning, Mazandaran Province, Northern Iran

BACKGROUND: Zinc phosphide (ZnP) is a dark gray crystalline compound used as a rodenticide against rodents such as mice. ZnP poisoning may be accidental or suicidal. The aim of this study was to investigate the clinical manifestations and treatment management of hospitalized patients with ZnP poison...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghasempouri, Seyed Khosro, Zakariaei, Zakaria, Hoseininejad, Seyed Mohammad, Chinian, Fatemeh, Soleymanii, Mostafa, Pashaei, Seyedeh Masoumeh, Sadeghi, Mahdieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188259/
https://www.ncbi.nlm.nih.gov/pubmed/35690724
http://dx.doi.org/10.1186/s12873-022-00661-1
_version_ 1784725335262101504
author Ghasempouri, Seyed Khosro
Zakariaei, Zakaria
Hoseininejad, Seyed Mohammad
Chinian, Fatemeh
Soleymanii, Mostafa
Pashaei, Seyedeh Masoumeh
Sadeghi, Mahdieh
author_facet Ghasempouri, Seyed Khosro
Zakariaei, Zakaria
Hoseininejad, Seyed Mohammad
Chinian, Fatemeh
Soleymanii, Mostafa
Pashaei, Seyedeh Masoumeh
Sadeghi, Mahdieh
author_sort Ghasempouri, Seyed Khosro
collection PubMed
description BACKGROUND: Zinc phosphide (ZnP) is a dark gray crystalline compound used as a rodenticide against rodents such as mice. ZnP poisoning may be accidental or suicidal. The aim of this study was to investigate the clinical manifestations and treatment management of hospitalized patients with ZnP poisoning in Mazandaran Province, northern Iran. METHODS: Between 2013 and 2017, a cross-sectional study was performed on hospitalized patients with ZnP poisoning who were referred to two training hospitals in Mazandaran Province, northern Iran. RESULTS: A total of 127 patients participated in this trial, including 71 (55.9%) men and 56 (44.1%) women. The patients’ average (standard deviation) age was 25.5 (±16.82) years, and it took 2.18 (±2.23) hours to refer them to the hospital. There were 42 (33%) cases with less than one package, 9 (7%) cases with several packages, and 76 (60%) cases with no particular usage. CONCLUSIONS: This study has shown that ZnP poisoning may be asymptomatic initially or with mild clinical symptoms that may gradually worsen. Therefore, hospitalization and obtaining a history and a careful physical examination should be considered.
format Online
Article
Text
id pubmed-9188259
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91882592022-06-12 Clinical manifestations and treatment management of hospitalized patients with zinc phosphide poisoning, Mazandaran Province, Northern Iran Ghasempouri, Seyed Khosro Zakariaei, Zakaria Hoseininejad, Seyed Mohammad Chinian, Fatemeh Soleymanii, Mostafa Pashaei, Seyedeh Masoumeh Sadeghi, Mahdieh BMC Emerg Med Research BACKGROUND: Zinc phosphide (ZnP) is a dark gray crystalline compound used as a rodenticide against rodents such as mice. ZnP poisoning may be accidental or suicidal. The aim of this study was to investigate the clinical manifestations and treatment management of hospitalized patients with ZnP poisoning in Mazandaran Province, northern Iran. METHODS: Between 2013 and 2017, a cross-sectional study was performed on hospitalized patients with ZnP poisoning who were referred to two training hospitals in Mazandaran Province, northern Iran. RESULTS: A total of 127 patients participated in this trial, including 71 (55.9%) men and 56 (44.1%) women. The patients’ average (standard deviation) age was 25.5 (±16.82) years, and it took 2.18 (±2.23) hours to refer them to the hospital. There were 42 (33%) cases with less than one package, 9 (7%) cases with several packages, and 76 (60%) cases with no particular usage. CONCLUSIONS: This study has shown that ZnP poisoning may be asymptomatic initially or with mild clinical symptoms that may gradually worsen. Therefore, hospitalization and obtaining a history and a careful physical examination should be considered. BioMed Central 2022-06-11 /pmc/articles/PMC9188259/ /pubmed/35690724 http://dx.doi.org/10.1186/s12873-022-00661-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ghasempouri, Seyed Khosro
Zakariaei, Zakaria
Hoseininejad, Seyed Mohammad
Chinian, Fatemeh
Soleymanii, Mostafa
Pashaei, Seyedeh Masoumeh
Sadeghi, Mahdieh
Clinical manifestations and treatment management of hospitalized patients with zinc phosphide poisoning, Mazandaran Province, Northern Iran
title Clinical manifestations and treatment management of hospitalized patients with zinc phosphide poisoning, Mazandaran Province, Northern Iran
title_full Clinical manifestations and treatment management of hospitalized patients with zinc phosphide poisoning, Mazandaran Province, Northern Iran
title_fullStr Clinical manifestations and treatment management of hospitalized patients with zinc phosphide poisoning, Mazandaran Province, Northern Iran
title_full_unstemmed Clinical manifestations and treatment management of hospitalized patients with zinc phosphide poisoning, Mazandaran Province, Northern Iran
title_short Clinical manifestations and treatment management of hospitalized patients with zinc phosphide poisoning, Mazandaran Province, Northern Iran
title_sort clinical manifestations and treatment management of hospitalized patients with zinc phosphide poisoning, mazandaran province, northern iran
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188259/
https://www.ncbi.nlm.nih.gov/pubmed/35690724
http://dx.doi.org/10.1186/s12873-022-00661-1
work_keys_str_mv AT ghasempouriseyedkhosro clinicalmanifestationsandtreatmentmanagementofhospitalizedpatientswithzincphosphidepoisoningmazandaranprovincenortherniran
AT zakariaeizakaria clinicalmanifestationsandtreatmentmanagementofhospitalizedpatientswithzincphosphidepoisoningmazandaranprovincenortherniran
AT hoseininejadseyedmohammad clinicalmanifestationsandtreatmentmanagementofhospitalizedpatientswithzincphosphidepoisoningmazandaranprovincenortherniran
AT chinianfatemeh clinicalmanifestationsandtreatmentmanagementofhospitalizedpatientswithzincphosphidepoisoningmazandaranprovincenortherniran
AT soleymaniimostafa clinicalmanifestationsandtreatmentmanagementofhospitalizedpatientswithzincphosphidepoisoningmazandaranprovincenortherniran
AT pashaeiseyedehmasoumeh clinicalmanifestationsandtreatmentmanagementofhospitalizedpatientswithzincphosphidepoisoningmazandaranprovincenortherniran
AT sadeghimahdieh clinicalmanifestationsandtreatmentmanagementofhospitalizedpatientswithzincphosphidepoisoningmazandaranprovincenortherniran